» Articles » PMID: 28487363

Modeling Oxygen Requirements in Ischemic Cardiomyocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 May 11
PMID 28487363
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Heart disease remains the leading cause of death globally. Although reperfusion following myocardial ischemia can prevent death by restoring nutrient flow, ischemia/reperfusion injury can cause significant heart damage. The mechanisms that drive ischemia/reperfusion injury are not well understood; currently, few methods can predict the state of the cardiac muscle cell and its metabolic conditions during ischemia. Here, we explored the energetic sustainability of cardiomyocytes, using a model for cellular metabolism to predict the levels of ATP following hypoxia. We modeled glycolytic metabolism with a system of coupled ordinary differential equations describing the individual metabolic reactions within the cardiomyocyte over time. Reduced oxygen levels and ATP consumption rates were simulated to characterize metabolite responses to ischemia. By tracking biochemical species within the cell, our model enables prediction of the cell's condition up to the moment of reperfusion. The simulations revealed a distinct transition between energetically sustainable and unsustainable ATP concentrations for various energetic demands. Our model illustrates how even low oxygen concentrations allow the cell to perform essential functions. We found that the oxygen level required for a sustainable level of ATP increases roughly linearly with the ATP consumption rate. An extracellular O concentration of ∼0.007 mm could supply basic energy needs in non-beating cardiomyocytes, suggesting that increased collateral circulation may provide an important source of oxygen to sustain the cardiomyocyte during extended ischemia. Our model provides a time-dependent framework for studying various intervention strategies to change the outcome of reperfusion.

Citing Articles

In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes.

Forouzandehmehr M, Paci M, Hyttinen J, Koivumaki J Dis Model Mech. 2024; 17(4).

PMID: 38516812 PMC: 11073514. DOI: 10.1242/dmm.050365.


Eugenol attenuates ischemia-mediated oxidative stress in cardiomyocytes via acetylation of histone at H3K27.

Randhawa P, Rajakumar A, Futuro de Lima I, Gupta M Free Radic Biol Med. 2022; 194:326-336.

PMID: 36526244 PMC: 10074330. DOI: 10.1016/j.freeradbiomed.2022.12.007.


Oxygen-Generating Scaffolds for Cardiac Tissue Engineering Applications.

Suvarnapathaki S, Nguyen A, Goulopoulos A, Camci-Unal G ACS Biomater Sci Eng. 2022; 9(1):409-426.

PMID: 36469567 PMC: 11416866. DOI: 10.1021/acsbiomaterials.2c00853.


A computational model of cardiomyocyte metabolism predicts unique reperfusion protocols capable of reducing cell damage during ischemia/reperfusion.

Grass M, McDougal A, Blazeski A, Kamm R, Garcia-Cardena G, Dewey Jr C J Biol Chem. 2022; 298(5):101693.

PMID: 35157851 PMC: 9062261. DOI: 10.1016/j.jbc.2022.101693.


A Recombinant Dimethylarginine Dimethylaminohydrolase-1-Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity.

Lee Y, Singh J, Scott S, Ellis B, Zorlutuna P, Wang M Mol Pharmacol. 2022; 101(4):226-235.

PMID: 35042831 PMC: 11033929. DOI: 10.1124/molpharm.121.000394.


References
1.
Finney A, Hucka M . Systems biology markup language: Level 2 and beyond. Biochem Soc Trans. 2003; 31(Pt 6):1472-3. DOI: 10.1042/bst0311472. View

2.
Moxley M, Beard D, Bazil J . Global Kinetic Analysis of Mammalian E3 Reveals pH-dependent NAD+/NADH Regulation, Physiological Kinetic Reversibility, and Catalytic Optimum. J Biol Chem. 2015; 291(6):2712-30. PMC: 4742739. DOI: 10.1074/jbc.M115.676619. View

3.
Chouchani E, Methner C, Nadtochiy S, Logan A, Pell V, Ding S . Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med. 2013; 19(6):753-9. PMC: 4019998. DOI: 10.1038/nm.3212. View

4.
Murphy E, Steenbergen C . Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008; 88(2):581-609. PMC: 3199571. DOI: 10.1152/physrev.00024.2007. View

5.
Seiler C, Stoller M, Pitt B, Meier P . The human coronary collateral circulation: development and clinical importance. Eur Heart J. 2013; 34(34):2674-82. DOI: 10.1093/eurheartj/eht195. View